GL1X · GenesisL1 explorer

UniProt O75164

Lysine-specific demethylase 4A (O75164)

Lysine-specific demethylase 4A (UniProt O75164), EC 1.14.11.-, 1.14.11.27: 167 experimental structures on GenesisL1, 45 ligands bound, 222 pockets. Binding sites, pockets, druggability and 3D structures in GL1X.

UniProt
O75164
Protein
Lysine-specific demethylase 4A
EC
1.14.11.-, 1.14.11.27, 1.14.11.66, 1.14.11.69
Experimental structures
167
Predicted models
0
Ligands
45
Pockets
222 · 18 records with a druggable one

Structures

167 records of O75164 in the MolNFT archive: 167 experimental, 0 predicted.

EntryTitleMethodChainsLigandsPockets
2GF7Double tudor domain structurex-ray diffractionA, B, C, D——
2GF7Double tudor domain structurex-ray diffractionA, B, C, D——
2GFAdouble tudor domain complex structurex-ray diffractionA, B——
2GFADouble tudor domain complex structurex-ray diffractionA, B——
2GP3Crystal structure of the catalytic core domain of jmjd2ax-ray diffractionA, B——
2GP3Crystal structure of the catalytic core domain of JMJD2Ax-ray diffractionA, B——
2GP5Crystal structure of catalytic core domain of jmjd2A complexed with alpha-Ketoglutaratex-ray diffractionA, B——
2GP5Crystal structure of catalytic core domain of JMJD2A complexed with alpha-ketoglutaratex-ray diffractionA, B——
2OQ6Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys9x-ray diffractionA, B——
2OQ6Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at LYS9x-ray diffractionA, B——
2OQ7The crystal structure of JMJD2A complexed with Ni and N-oxalylglycinex-ray diffractionA, B——
2OQ7The crystal structure of JMJD2A complexed with ni and N-oxalylglycinex-ray diffractionA, B——
2OS2Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at Lys36x-ray diffractionA, B——
2OS2Crystal structure of JMJD2A complexed with histone H3 peptide trimethylated at LYS36x-ray diffractionA, B——
2OT7Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at Lys9x-ray diffractionA, B——
2OT7Crystal structure of JMJD2A complexed with histone H3 peptide monomethylated at LYS9x-ray diffractionA, B——
2OX0Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at Lys9x-ray diffractionA, B——
2OX0Crystal structure of JMJD2A complexed with histone H3 peptide dimethylated at LYS9x-ray diffractionA, B——
2P5BThe complex structure of JMJD2A and trimethylated H3K36 peptidex-ray diffractionA, B——
2P5BThe complex structure of JMJD2A and trimethylated H3K36 peptidex-ray diffractionA, B——
2PXJThe complex structure of JMJD2A and monomethylated H3K36 peptidex-ray diffractionA, B——
2PXJThe complex structure of JMJD2A and monomethylated H3K36 peptidex-ray diffractionA, B——
2Q8CCrystal structure of JMJD2A in ternary complex with an histone H3K9me3 peptide and 2-oxoglutaratex-ray diffractionA, B——
2Q8CCrystal structure of JMJD2A in ternary complex with an histone H3K9ME3 peptide and 2-oxoglutaratex-ray diffractionA, B——
2Q8DCrystal structure of JMJ2D2A in ternary complex with histone H3-K36me2 and succinatex-ray diffractionA, B——
2Q8DCrystal structure of JMJ2D2A in ternary complex with histone H3-K36ME2 and succinatex-ray diffractionA, B——
2Q8ESpecificity and Mechanism of JMJD2A, a Trimethyllysine-Specific Histone Demethylasex-ray diffractionA, B——
2Q8ESpecificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylasex-ray diffractionA, B——
2QQRJMJD2A hybrid tudor domainsx-ray diffractionA, B——
2QQRJMJD2A hybrid tudor domainsx-ray diffractionA, B——
2QQSJMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptidex-ray diffractionA, B——
2QQSJMJD2A tandem tudor domains in complex with a trimethylated histone H4-K20 peptidex-ray diffractionA, B——
2VD7Crystal Structure of JMJD2A complexed with inhibitor Pyridine-2,4- dicarboxylic acidx-ray diffractionA, B——
2VD7Crystal structure of JMJD2A complexed with inhibitor pyridine-2,4- dicarboxylic acidx-ray diffractionA, B——
2WWJStructure of JMJD2A complexed with inhibitor 10Ax-ray diffractionA, B——
2WWJStructure of JMJD2A complexed with inhibitor 10Ax-ray diffractionA, B——
2YBKJMJD2A complexed with R-2-hydroxyglutaratex-ray diffractionA, B——
2YBKJMJD2A complexed with R-2-hydroxyglutaratex-ray diffractionA, B——
2YBPJMJD2A COMPLEXED WITH R-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41)x-ray diffractionA, B——
2YBPJMJD2A complexed with R-2-hydroxyglutarate and histone H3K36ME3 peptide (30-41)x-ray diffractionA, B——
2YBSJMJD2A COMPLEXED WITH S-2-HYDROXYGLUTARATE AND HISTONE H3K36me3 PEPTIDE (30-41)x-ray diffractionA, B——
2YBSJMJD2A complexed with S-2-hydroxyglutarate and histone H3K36ME3 peptide (30-41)x-ray diffractionA, B——
3NJYCrystal structure of JMJD2A complexed with 5-carboxy-8-hydroxyquinolinex-ray diffractionA, B——
3NJYCrystal structure of JMJD2A complexed with 5-carboxy-8- hydroxyquinolinex-ray diffractionA, B——
3PDQCrystal structure of JMJD2A complexed with bipyridyl inhibitorx-ray diffractionA, B——
3PDQCrystal structure of JMJD2A complexed with bipyridyl inhibitorx-ray diffractionA, B——
3RVHCrystal Structure of JMJD2A Complexed with Inhibitorx-ray diffractionA, B——
3RVHCrystal structure of JMJD2A complexed with inhibitorx-ray diffractionA, B——
3U4SHistone Lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to…x-ray diffractionA, B——
3U4SHistone lysine demethylase JMJD2A in complex with T11C peptide substrate crosslinked to…x-ray diffractionA, B——
4AI9JMJD2A Complexed with Daminozidex-ray diffractionA, B——
4AI9JMJD2A complexed with daminozidex-ray diffractionA, B——
4BISJMJD2A complexed with 8-hydroxyquinoline-4-carboxylic acidx-ray diffractionA, B——
4BISJMJD2A complexed with 8-hydroxyquinoline-4-carboxylic acidx-ray diffractionA, B——
4GD4Crystal Structure of JMJD2A Complexed with Inhibitorx-ray diffractionA, B——
4GD4Crystal structure of JMJD2A complexed with inhibitorx-ray diffractionA, B——
4URACrystal structure of human JMJD2A in complex with compound 14ax-ray diffractionA, B——
4URACrystal structure of human JMJD2A in complex with compound 14Ax-ray diffractionA, B——
4V2VJMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27me3 PEPTIDE (25-29) ARK(me3)SAx-ray diffractionA, B——
4V2VJMJD2A complexed with NI(II), nog and histone H3K27ME3 peptide (25-29) ARK(ME3)SAx-ray diffractionA, B——

107 records more on the page itself.

Ligands

  • ZN · Zinc ion · in 63 records
  • CL · Chloride ion · in 33 records
  • NI · Nickel (II) ion · in 30 records
  • SO4 · Sulfate ion · in 8 records
  • OGA · N-oxalylglycine · in 6 records
  • FO2 · 8-[4-(1-methylpiperidin-4-yl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 4 records
  • 48V · {[(2R)-2,3-diamino-3-oxopropyl]sulfanyl}acetic acid · in 2 records
  • 92Y · (1R,2S,3R,4S)-3-[(dimethylamino)methyl]-1-phenylbicyclo[2.2.1]heptan-2-ol · in 2 records
  • 9DJ · 3-[({(1R)-6-[methyl(phenyl)amino]-1,2,3,4-tetrahydronaphthalen-1-yl}methyl)amino]pyridine-4-carboxylic acid · in 2 records
  • 9FJ · 3-({[(1R)-6-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl]methyl}amino)pyridine-4-carboxylic acid · in 2 records
  • AKG · 2-oxoglutaric acid · in 2 records
  • DHB · 3,4-dihydroxybenzoic acid · in 2 records
  • FO8 · 8-[4-[2-[4-[4-(2-morpholin-4-ylethyl)phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FOW · 8-[4-(2-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylethyl)pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FQ5 · 8-[4-[2-[4-(3-chlorophenyl)piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FQB · 8-[4-[2-[4-[4-[2-(dimethylamino)ethyl]phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FQE · 8-[4-[2-[4-[3-[2-(dimethylamino)ethyl]phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FQH · 8-[4-[2-[4-[3-(trifluoromethyl)phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FQQ · 8-[4-[2-[4-(3-chlorophenyl)-4-methyl-piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 2 records
  • FUM · Fumaric acid · in 2 records
  • MN · Manganese (II) ion · in 2 records
  • MY7 · 2-(3-methyl-5-oxidanylidene-4-phenyl-4~{H}-pyrazol-1-yl)-3~{H}-benzimidazole-5-carboxylic acid · in 2 records
  • QC1 · 3-{[(4-fluorophenyl)methyl]amino}pyridine-4-carboxylic acid · in 2 records
  • QC2 · 2-[5-(3-hydroxyphenyl)-1H-pyrazol-1-yl]pyridine-4-carboxylic acid · in 2 records
  • 1KA · (2-hydroxyethoxy)acetaldehyde · in 1 record
  • 5TZ · 2-(2-azanyl-1,3-thiazol-4-yl)pyridine-4-carboxylic acid · in 1 record
  • 5U8 · 8-[4-[2-[(4-fluorophenyl)methyl-methyl-amino]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 1 record
  • 5UB · 8-(1,3-thiazol-4-yl)-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 1 record
  • 5UJ · 8-[4-[2-[4-[3,5-bis(chloranyl)phenyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 1 record
  • 5UL · 8-[4-[2-[4-[(4-chlorophenyl)methyl]piperidin-1-yl]ethyl]pyrazol-1-yl]-3~{H}-pyrido[3,4-d]pyrimidin-4-one · in 1 record

Elsewhere

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.